Aymanshafei (Talk | contribs) |
Aymanshafei (Talk | contribs) |
||
Line 126: | Line 126: | ||
<a>PROJECT <span class="caret"></span></a> | <a>PROJECT <span class="caret"></span></a> | ||
<ul> | <ul> | ||
− | <li><a href="https://2017.igem.org/Project.html">Project | + | <li><a href="https://2017.igem.org/Project.html">Project Description</a></li> |
<li><a href="https://2017.igem.org/Experiment.html">Experiment</a></li> | <li><a href="https://2017.igem.org/Experiment.html">Experiment</a></li> | ||
<li><a href="https://2017.igem.org/Result.html">Result</a></li> | <li><a href="https://2017.igem.org/Result.html">Result</a></li> |
Revision as of 15:05, 21 October 2017
Abstract
Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers
in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-.
"Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique
that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma.
This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.
This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.